Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
PRNewswire - December 5, 2000
The purpose of the testing is to validate and to substantiate previous test results obtained as well as increase the amount of clinical data available for analysis.
Previous Human clinical studies of the HIV/AIDS treatment have demonstrated a significant improvement in the health care status of 60 out of 70 individuals within a 90 to 120 day time frame.
The Medical and Scientific Advisory Committee will also assist in the development and implementation of testing protocols to be compliant with FDA standards. "We anticipate entering into the first clinical phase of testing for FDA approval in the United States within the next 30 days," Robert Talbot, President of Medical Resorts International.
Safe Harbor Act Notice: This release may contain forward-looking statements that involve risks and uncertainties, including, without limitation, acceptance of the company's products, increased levels of competition, product and technological changes, the company's dependence upon financing and third-party suppliers, and other risks detailed from time to time in the company's federal filings, annual report, offering memorandum, or prospectus. Specifications are subject to change without notice.
SOURCE Medical Resorts International Web Site: http://www.medicalresorts.com
001205
PR001220
Copyright © 2000 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .